Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis
Authors:
Open Access
- 22 December 2005
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 23 (2) , 303-312
Abstract
Summary: Background Rectal budesonide is an effective treatment of active ulcerative proctitis or proctosigmoiditis.Aim To compare the therapeutic efficacy, tolerability and safety, and patient's preference of budesonide foam vs. budesonide enema.Methods Patients with active ulcerative proctitis or proctosigmoiditis (clinical activity index >4 and endoscopic index ≥4) were eligible for this double‐blind, double‐dummy, randomized, multicentre study. They received 2 mg/25 mL budesonide foam and placebo enema (n = 265), or 2 mg/100 mL budesonide enema and placebo foam (n = 268) for 4 weeks. Primary endpoint was clinical remission (clinical activity index ≤4) at the final/withdrawal visit (per protocol).Results A total of 541 patients were randomized – 533 were evaluable for intention‐to‐treat analysis and 449 for per protocol analysis. Clinical remission rates (per protocol) were 60% for budesonide foam and 66% for budesonide enema (P = 0.02362 for non‐inferiority of foam vs. enema within a predefined non‐inferiority margin of 15%). Both formulations were safe and no drug‐related serious adverse events were observed. Because of better tolerability and easier application most patients preferred foam (84%).Conclusion Budesonide foam is as effective as budesonide enema in the treatment of active ulcerative proctitis or proctosigmoiditis. Both budesonide formulations are safe, and most patients prefer foam.Keywords
This publication has 21 references indexed in Scilit:
- Budesonide Foam vs . Hydrocortisone Acetate Foam in the Treatment of Active Ulcerative ProctosigmoiditisDiseases of the Colon & Rectum, 2003
- Budesonid-Schaum als neues Therapieprinzip bei der distalen Colitis ulcerosa im Vergleich mit Mesalazin-Klysmen. Eine offene, kontrollierte, randomisierte und prospektive multizentrische PilotstudieZeitschrift für Gastroenterologie, 2000
- Nuclear factor κB in liver diseaseGut, 1999
- Open, randomised, multicenter trial comparing safety and efficacy of budesonide-foam with betamethasone enema in patients with active distal ulcerative colitisGastroenterology, 1998
- Budesonide enema is an effective alternative to hydrocortisone enema in active distal ulcerative colitisGastroenterology, 1995
- Comparative trial of methylprednisolone and budesonide enemas in active distal ulcerative colitisEuropean Journal of Gastroenterology & Hepatology, 1994
- A Steroid Enema, Budesonide, Lacking Systemic Effects for the Treatment of Distal Ulcerative Colitis or ProctitisScandinavian Journal of Gastroenterology, 1992
- Budesonide Enema in Distal Ulcerative Colitis: a Randomized Dose-Response Trial with Prednisolone Enema as Positive ControlScandinavian Journal of Gastroenterology, 1991
- Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non‐zero risk difference or non‐unity relative riskStatistics in Medicine, 1990
- A Controlled Randomized Trial of Budesonide versus Prednisolone Retention Enemas in Active Distal Ulcerative ColitisScandinavian Journal of Gastroenterology, 1987